SCHEMBL20205727

SCHEMBL20205727

CC1(C)c2cc(-c3ccc4c(c3)oc3ccccc34)c3oc4ccccc4c3c2-c2ccc3c(c21)C(C)(C)c1cc(-c2ccc4c(c2)oc2ccccc24)c2oc4ccccc4c2c1-3

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 2/20 0.39
▸ PRKDC P78527 1/20 0.36
▸ AHR P35869 2/20 0.35
▸ MEN1 O00255 4/20 0.34
▸ KMT2A Q03164 4/20 0.34
▸ MAPT P10636 3/20 0.34
▸ KDM4E B2RXH2 2/20 0.34
▸ HPGD P15428 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ PGR P06401 2/20 0.34
▸ PTGER4 P35408 1/20 0.33
▸ CDC14B O60729 2/20 0.33
▸ CDC14A Q9UNH5 2/20 0.33
▸ MMP12 P39900 1/20 0.33
▸ MMP13 P45452 1/20 0.33
▸ TTR P02766 1/20 0.33
▸ CYP2C19 P33261 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ ALPI P09923 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20205429 0.96 ALOX5 (0.36) ALOX5PRKDCAHRMEN1KMT2A
SCHEMBL20205598 0.94 ALOX5 (0.35) ALOX5PRKDCAHRMEN1KMT2A
SCHEMBL20205592 0.92 TDP1 (0.36) ALOX5PRKDCAHRL3MBTL1HCRTR1
SCHEMBL20205648 0.91 ALOX5 (0.39) ALOX5PRKDCAHRMEN1KMT2A
SCHEMBL20205647 0.91 ALOX5 (0.38) ALOX5PRKDCAHRMEN1KMT2A
SCHEMBL20205587 0.90 ALOX5 (0.33) ALOX5PRKDCPGR
SCHEMBL20205318 0.89 CDC14B (0.39) ALOX5MEN1KMT2AMAPTHPGD
SCHEMBL20205308 0.89 CDC14B (0.41) ALOX5MEN1KMT2AMAPTHPGD
SCHEMBL20205631 0.88 ALOX5 (0.36) ALOX5PRKDCAHRMEN1KMT2A
SCHEMBL23351982 0.88 CDC14B (0.36) ALOX5PRKDCMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND ALOX5 354/4885PRKDC 4001/4885AHR 1079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback